Guest guest Posted December 30, 2006 Report Share Posted December 30, 2006 Hi Was advised to take Lithium on a couple of occasions. Once by a psychiatrist and once by a GP. Decided against it. A friend, who is on Lithium, has recently been taken off Olanzapine because they have developed diabetes and the professionals think it is the Olanzapine that caused it. I am no wiser than anyone else but to me the Lithium is just as dangerous as the other drug. Am struggling at present not to become reliant on Lorazees. They are emergency supplies for me and I know that goes against the grain of the anti-meds view which I tend to err with. My only defense is that more often than not it is a case of surviving the day rather than looking at what constitutes a more balanced life. Haven't taken one for 2 days...which for me is mega achievement as head is screwing big time. Anyway enough of that. Am aware that psychiatric drugs can and do have horrendous side effects either short or long term and that there are some very fat cats getting fatter on other people's suffering. Mandy Long-term lithium treatment causes serotonin receptor down-regulation http://www.ncbi.nlm.nih.gov/entrez/query.fcgi? cmd=Retrieve & db=PubMed & list_uids=3494960 & dopt=Abstract Long-term lithium treatment causes serotonin receptor down-regulation via serotonergic presynapses in rat brain. Hotta I, Yamawaki S, Segawa T. The effects of lithium treatment on serotonin (5-HT) receptors in rat frontal cortex and hippocampus were investigated. Long-term lithium treatment strongly blocked 5-hydroxytryptophan-induced head twitches, while acute lithium administration by itself induced head twitches in rats, and ketanserin blocked this acute lithium action. Long-term administration of lithium decreased the number of not only 5-HT2 receptors in the frontal cortex but also 5-HT1 and 5-HT2 receptors in the hippocampus in rats. Decreases in 3H-5-HT binding to hippocampal 5-HT1 receptors and 3H-spiperone binding to frontal cortical 5-HT2 receptors, caused by chronic lithium treatment, were abolished by co- administration of p-chlorophenylalanine, and were enhanced by co- administration with methiothepin. The turnover of 5-HT in either frontal cortex or hippocampus was facilitated by lithium, and co- administered methiothepin enhanced this facilitation. These results suggest that long-term lithium treatment causes the down-regulation of postsynaptic 5-HT1 and 5-HT2 receptors, in part probably through its action on presynaptic nerve terminals. Publication Types: In Vitro Research Support, Non-U.S. Gov't PMID: 3494960 [PubMed - indexed for MEDLINE] ------------------------------------------------------------------------------ No virus found in this incoming message. Checked by AVG Free Edition. Version: 7.1.409 / Virus Database: 268.16.0/609 - Release Date: 29/12/06 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.